![](/img/cover-not-exists.png)
Preclinical Characterization of GLPG0634, a Selective Inhibitor of JAK1, for the Treatment of Inflammatory Diseases
Van Rompaey, L., Galien, R., van der Aar, E. M., Clement-Lacroix, P., Nelles, L., Smets, B., Lepescheux, L., Christophe, T., Conrath, K., Vandeghinste, N., Vayssiere, B., De Vos, S., Fletcher, S., BryVolume:
191
Language:
english
Journal:
The Journal of Immunology
DOI:
10.4049/jimmunol.1201348
Date:
October, 2013
File:
PDF, 1.13 MB
english, 2013